These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11792984)

  • 1. Impact of hepatitis B core antibody status on outcomes of cadaveric renal transplantation: analysis of United network of organ sharing database between 1994 and 1999.
    Fong TL; Bunnapradist S; Jordan SC; Cho YW
    Transplantation; 2002 Jan; 73(1):85-9. PubMed ID: 11792984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.
    Fabrizio F; Bunnapradist S; Martin P
    J Nephrol; 2002; 15(6):605-13. PubMed ID: 12495272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney transplantation from anti-HBc+ donors: results from a retrospective Italian study.
    De Feo TM; Grossi P; Poli F; Mozzi F; Messa P; Minetti E; Sandrini S; Boschiero L; Rigotti P; Maresca C; Rolla D; Chiaramonte S; Gotti E; Caldara R; Briano G; Scalamogna M
    Transplantation; 2006 Jan; 81(1):76-80. PubMed ID: 16421480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients.
    Wang XD; Feng SJ; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
    BMC Infect Dis; 2021 Jan; 21(1):41. PubMed ID: 33422017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients.
    Veroux M; Puliatti C; Gagliano M; Cappello D; Macarone M; Vizcarra D; Spataro M; Di Mare M; Ginevra N; Veroux P
    Transplant Proc; 2005; 37(6):2574-5. PubMed ID: 16182748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks of transplanting kidneys from hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors.
    Satterthwaite R; Ozgu I; Shidban H; Aswad S; Sunga V; Zapanta R; Asai P; Bogaard T; Khetan U; Mendez RG; Mendez R
    Transplantation; 1997 Aug; 64(3):432-5. PubMed ID: 9275109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Induction Type Influence Outcomes in Kidney Transplant Recipients at Different Phases of Hepatitis B Infection?
    Sureshkumar KK; Chopra B
    Exp Clin Transplant; 2019 Aug; 17(4):457-460. PubMed ID: 30066624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A decade of experience with renal transplantation in African-Americans.
    Foster CE; Philosophe B; Schweitzer EJ; Colonna JO; Farney AC; Jarrell B; Anderson L; Bartlett ST
    Ann Surg; 2002 Dec; 236(6):794-804; discussion 804-805. PubMed ID: 12454518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus).
    Natov SN; Pereira BJ
    Transpl Infect Dis; 2002 Sep; 4(3):117-23. PubMed ID: 12421455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.
    Yu L; Koepsell T; Manhart L; Ioannou G
    Liver Transpl; 2009 Oct; 15(10):1343-50. PubMed ID: 19790164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of Donors with Hepatitis B Core Antibodies in Liver Transplantation.
    Skalski M; Patkowski W; Grąt M; Zieniewicz K; Wróblewski T; Hołówko W; Krawczyk M
    Ann Transplant; 2015 Nov; 20():667-75. PubMed ID: 26552722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of united network for organ sharing data.
    Bresnahan BA; McBride MA; Cherikh WS; Hariharan S
    Transplantation; 2001 Jul; 72(2):256-61. PubMed ID: 11477349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
    World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine.
    Nery JR; Nery-Avila C; Reddy KR; Cirocco R; Weppler D; Levi DM; Nishida S; Madariaga J; Kato T; Ruiz P; Schiff E; Tzakis AG
    Transplantation; 2003 Apr; 75(8):1179-86. PubMed ID: 12717200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.
    Donataccio D; Roggen F; De Reyck C; Verbaandert C; Bodeus M; Lerut J
    Transpl Int; 2006 Jan; 19(1):38-43. PubMed ID: 16359375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature.
    Mahboobi N; Tabatabaei SV; Blum HE; Alavian SM
    Transpl Infect Dis; 2012 Oct; 14(5):445-51. PubMed ID: 22970743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
    Dodson SF; Bonham CA; Geller DA; Cacciarelli TV; Rakela J; Fung JJ
    Transplantation; 1999 Oct; 68(7):1058-61. PubMed ID: 10532552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease.
    Madayag RM; Johnson LB; Bartlett ST; Schweitzer EJ; Constantine NT; McCarter RJ; Kuo PC; Keay S; Oldach DW
    Transplantation; 1997 Dec; 64(12):1781-6. PubMed ID: 9422420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.